Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 19 2013
Print

Industry News

Related Searches:

Filter by:

August 15, 2007
Millipore Corp. expanded its agreement with Novo Nordisk to provide recombinant human insulin, a key cell culture supplement used to manufacture biologic drugs. Under the terms of the agreement, Millipore will have exclusive worldwide rights to…   Read More »
August 15, 2007
Sancilio & Company, Inc. is expanding the analytical services offered through its FDA and DEA registered cGMP analytical chemistry lab at SCI's Riviera Beach, FL location. Dr. Nealie Newberger, formerly of the Analytical Services Lab at SCI,…   Read More »
August 10, 2007
Bilcare has begun a capital investment project in an effort to enhance its global footprint and increase capacity and capabilities. The company is upgrading its packaging, storage and distribution facilities at its U.S. headquarters in Phoenixville,…   Read More »
August 7, 2007
Following yesterday's approval of HIV drug Selzentry, Pfizer chose to issue a statement regarding its clinical pipeline. The company announced that it has 47 active programs in its Phase II R&D pipeline—the largest in its history—and…   Read More »
August 7, 2007
Althea Technologies, Inc. has been selected by GeoVax Labs, Inc., an Atlanta-based biotechnology company, to manufacture its HIV-1 DNA (AIDS) vaccine for GeoVax’s Phase II trials, expected to begin in early 2008. GeoVax AIDS vaccines ar…   Read More »
August 7, 2007
Integrated Project Services (IPS) broke ground for RxElite Holdings, Inc.'s new Greenfield headquarters, distribution center and future manufacturing facility located in Nampa, ID. RxElite is engaged in the formulation and manufacture of specialty ge…   Read More »
August 1, 2007
Johnson & Johnson is restructuring and plans to reduce its global work force by 4% or approximately 4,820 jobs, in an effort to counter losses as a result of falling sales of its heart stents due to safety concerns and impending patent expiration…   Read More »
August 1, 2007
Abraxis BioScience, Inc. has acquired a sterile injectable manufacturing facility in Phoenix, AZ, from Watson Pharmaceuticals, Inc. This facility currently manufactures products for both Watson and third parties and is capable of manufacturing lyophi…   Read More »
August 1, 2007
MDS Pharma Services is expanding its Development & Regulatory Services (DRS) business in Europe and will now offer full-service DRS consulting services to support development of new drugs and biopharmaceutical products for clients in Europe. The…   Read More »
July 31, 2007
Laureate Pharma, Inc. has entered into a cGMP contract manufacturing agreement with Enobia Pharma, a biotechnology company developing an enzyme replacement therapy for the treatment of hypophosphatasia. Under the agreement, Laureate will produce Enob…   Read More »
July 31, 2007
PPD, Inc. plans to expand its operations in Bellshill, Lanarkshire, in an effort to meet the increasing demand for its drug development services. The company expects to invest as much as $30 million to expand its offices in this location during the n…   Read More »
July 30, 2007
OSG Norwich Pharmaceuticals, a CMO based in Norwich, NY, has been acquired by AFI Partners, a NYC-based private equity group. The company, which was owned by Outsourcing Services Group, will now be known as Norwich Pharmaceuticals, Inc., and operatio…   Read More »
July 30, 2007
ImClone Systems and Bristol-Myers Squibb have amended the terms of their Erbitux agreement regarding the development and promotion in North America. Under this amendment, the companies have expanded the investment in the ongoing clinical development…   Read More »
July 30, 2007
Akorn, Inc. and Hyaluron Contract Manufacturing (HCM) have signed a development and supply agreement for two ANDA injectable suspension products. One of the products is an injectable sustained release pharmaceutical, which will be available in b…   Read More »
July 30, 2007
Crucell N.V. has entered into a co-exclusive PER.C6 and Advac technology license agreement with Wyeth. Under the terms of the agreement, Crucell will receive an upfront payment, milestone payments, annual maintenance fees, and royalties on product sa…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On